Skip to content

13F-HR filed by FARLEY CAPITAL L.P.

FARLEY CAPITAL L.P. filed this 13F-HR for the quarter ended 2017-06-30, filed 2017-08-14, with 12 holding rows worth $88,079,000.

Accession
0001144204-17-042858
Filed
2017-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2017

A holdings report, 12 entries on the cover page, a total value of $88,079,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $88,079,000 with VALUE read as thousands by filing date, 13F file number 028-15344. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
COVISTA INC00737L103COM1,318,776$50,048,000thousands by filing date
MasterCard, Inc57636Q104COM172,726$20,978,000thousands by filing date
Alphabet Inc. Reg. Shares C02079K107COM7,781$7,071,000thousands by filing date
VALEANT PHARMACEUTICALS INTL91911K102COM272,148$4,708,000thousands by filing date
CTRIP COM INTL LTD22943F100AMERICAN DEP SHS40,092$2,159,000thousands by filing date
Berkshire Hathaway Inc084670702COM4,773$808,000thousands by filing date
BAIDU INC SPON ADR REP A056752108ADR3,000$537,000thousands by filing date
Alphabet Inc. Reg. Shares A02079K305COM517$481,000thousands by filing date
PRAXAIR INC74005P104COM3,107$412,000thousands by filing date
EPAM SYS INC COM29414B104Stock3,900$328,000thousands by filing date
VALEANT PHARMACEUTICALS INTE91911K902COM17,000$294,000thousands by filing date
BERKSHIRE HATHAWAY INC DEL084670108CL A1$255,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001144204-17-042858this filing2017-08-14acceptance time not in the bulk data set